02.12.2010 • NewsNovartisRocheBayer

Novartis to Slash 1,400 U.S. Jobs

Novartis AG is to slash 1,400 U.S. jobs in its sales force for drugs used in general practice as it forges ahead with a push into specialty medicines and seeks to streamline its business ahead of patent expiries.

The cuts will come into effect on Jan 1, 2011 and the restructuring is expected to result in a one-time cost of around $85 million, the Swiss drugmaker said on Tuesday.

Novartis' pharmaceuticals business has over 13,000 employees in the United States, while the group as a whole has more than 18,000 workers there. The group has around 100,000 employees in total.

The news comes after cross-town rival Roche said it would slash around 6 percent of its workforce, while Germany's Bayer has said it is planning a 1 billion euro cost-cutting programme.

"There are new product launches expected within the primary care business and significant growth momentum within the specialty care business that will drive long-term success," Novartis said.

"Given these changing dynamics within the portfolio, it is critical to realign the general medicines field force to sharpen focus on the greatest opportunities for growth," the group said.

Earlier this month, Novartis said it was ramping up a group-wide efficiency drive and that it was starting to review its manufacturing as well as its marketing and sales processes.

Novartis, like most other companies in the pharmaceutical industry, will have to deal with a number of key drugs losing patent protection over the next few years, while pricing pressure in the United States and Europe is also making for a tough environment.

Company

Novartis Vaccines and Diagnostics GmbH & Co.KG

Postfach 1630
35006 Marburg
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.